The Japan Times - Formerra to Supply Foster Medical Compounds in Europe

EUR -
AED 4.240257
AFN 73.32143
ALL 96.053795
AMD 433.817139
ANG 2.066822
AOA 1058.764604
ARS 1599.696819
AUD 1.675026
AWG 2.078272
AZN 1.967396
BAM 1.955877
BBD 2.317892
BDT 141.205579
BGN 1.973561
BHD 0.434817
BIF 3418.53506
BMD 1.154596
BND 1.481959
BOB 7.981315
BRL 6.067751
BSD 1.150845
BTN 109.078309
BWP 15.865627
BYN 3.425635
BYR 22630.074075
BZD 2.314491
CAD 1.604715
CDF 2635.36902
CHF 0.917923
CLF 0.027055
CLP 1068.301597
CNY 7.980392
CNH 7.989998
COP 4229.267091
CRC 534.421114
CUC 1.154596
CUP 30.596784
CVE 110.269357
CZK 24.603629
DJF 204.928096
DKK 7.496448
DOP 68.502706
DZD 153.573067
EGP 60.780401
ERN 17.318934
ETB 177.904429
FJD 2.606389
FKP 0.868614
GBP 0.866456
GEL 3.094767
GGP 0.868614
GHS 12.609498
GIP 0.868614
GMD 84.867224
GNF 10090.398654
GTQ 8.807348
GYD 240.899518
HKD 9.036039
HNL 30.555207
HRK 7.557064
HTG 150.85596
HUF 390.276858
IDR 19617.503194
ILS 3.622683
IMP 0.868614
INR 109.51363
IQD 1507.559561
IRR 1516272.693223
ISK 144.047794
JEP 0.868614
JMD 181.147157
JOD 0.818654
JPY 185.066713
KES 149.485906
KGS 100.96983
KHR 4609.182101
KMF 494.167328
KPW 1039.005581
KRW 1741.130593
KWD 0.355512
KYD 0.959038
KZT 556.361981
LAK 25029.988892
LBP 103054.87152
LKR 362.514322
LRD 211.168343
LSL 19.761581
LTL 3.409221
LVL 0.698404
LYD 7.34629
MAD 10.755925
MDL 20.213799
MGA 4796.189489
MKD 61.642435
MMK 2427.526343
MNT 4123.646826
MOP 9.285467
MRU 45.949815
MUR 54.000874
MVR 17.838939
MWK 1995.478838
MXN 20.923702
MYR 4.530678
MZN 73.836825
NAD 19.761581
NGN 1597.337286
NIO 42.351673
NOK 11.20288
NPR 174.524895
NZD 2.015881
OMR 0.443458
PAB 1.150845
PEN 4.008858
PGK 4.973196
PHP 69.911197
PKR 321.19049
PLN 4.298271
PYG 7524.297272
QAR 4.195866
RON 5.111746
RSD 117.404638
RUB 93.863708
RWF 1680.566396
SAR 4.33291
SBD 9.285301
SCR 17.363686
SDG 693.912357
SEK 10.938258
SGD 1.49255
SHP 0.866246
SLE 28.345751
SLL 24211.30527
SOS 657.725986
SRD 43.413994
STD 23897.798134
STN 24.500968
SVC 10.069398
SYP 129.111885
SZL 19.759781
THB 37.518628
TJS 10.995934
TMT 4.041085
TND 3.392934
TOP 2.779989
TRY 51.310654
TTD 7.819309
TWD 36.998328
TZS 2969.117305
UAH 50.443693
UGX 4287.169379
USD 1.154596
UYU 46.58184
UZS 14034.554481
VES 540.268027
VND 30409.162038
VUV 138.27014
WST 3.204592
XAF 655.982917
XAG 0.0165
XAU 0.000256
XCD 3.120353
XCG 2.074082
XDR 0.815832
XOF 655.982917
XPF 119.331742
YER 275.490657
ZAR 19.766689
ZMK 10392.750198
ZMW 21.663856
ZWL 371.779317
  • RBGPF

    -13.5000

    69

    -19.57%

  • JRI

    -0.2700

    11.8

    -2.29%

  • BCC

    0.1400

    74.43

    +0.19%

  • VOD

    -0.1400

    14.49

    -0.97%

  • RYCEF

    -0.5900

    14.65

    -4.03%

  • CMSD

    -0.0900

    22.66

    -0.4%

  • RIO

    0.8500

    86.64

    +0.98%

  • NGG

    -0.4800

    81.92

    -0.59%

  • BCE

    -0.2200

    25.25

    -0.87%

  • RELX

    -0.1000

    31.97

    -0.31%

  • CMSC

    -0.0500

    22.77

    -0.22%

  • GSK

    -0.1000

    53.84

    -0.19%

  • BTI

    0.3749

    57.8

    +0.65%

  • AZN

    5.0200

    188.42

    +2.66%

  • BP

    0.5100

    46.68

    +1.09%

Formerra to Supply Foster Medical Compounds in Europe
Formerra to Supply Foster Medical Compounds in Europe

Formerra to Supply Foster Medical Compounds in Europe

Expanded agreement infuses Formerra's European healthcare polymer portfolio with life-saving Foster® compounds.

Text size:

PUTNAM, CT AND ROMEOVILLE, IL / ACCESS Newswire / January 29, 2026 / Formerra and GEON® Performance Solutions today announced an agreement that designates Formerra as the preferred distributor of Foster®, LLC medical compounds in Europe. This adds to Formerra's current distribution of these materials in North and South America, enabling Formerra to now support customers who need the same product in all regions.

Following GEON's January 2025 acquisition of Foster, the agreement builds on Formerra's long-standing, global partnership with GEON for flexible and rigid PVC and filled polypropylene materials.

"Bringing Foster's medical-grade portfolio to Europe strengthens our ability to support healthcare manufacturers across the region with specialized compounds and the local expertise they need to navigate complex regulatory environments," said Kelly Wessner, Vice President, Key Accounts, Formerra. "Building on the momentum of our Americas partnership, we're excited to extend these proven solutions to European customers who demand the highest standards in medical device materials."

With more than 30 years in custom medical polymer compounding, Foster delivers highly engineered, top-of-the-polymer-pyramid formulations tailored to demanding requirements. The portfolio includes options such as radiopaque compounds and grades that meet USP Class VI requirements and align with ISO 10993 expectations. These materials support critical end uses across the healthcare space, including implantable products and other highly specialized applications.

"Extending our Foster portfolio into Europe with Formerra allows us to meet growing demand from healthcare manufacturers in one of the world's most dynamic medical device markets," said Arthur Adams, Chief Commercial Officer, GEON. "This expansion reinforces our shared commitment to supporting innovation in life-saving applications globally."

Adding Foster® compounds to its European portfolio will enable Formerra to better serve customers in the healthcare space, offering not only access to highly engineered medical polymers, but also deep regulatory expertise and responsive logistics across the region.

Formerra will exhibit at MD&M West in Booth 2266 in Anaheim, California, February 3-5, 2026.

###

Key Details

  • Formerra will distribute Foster® medical compounds in Europe.

  • This agreement adds custom medical-grade compounds to Formerra's existing global access to GEON® PVC and filled PP materials.

About Formerra
Formerra is a preeminent distributor of engineered materials, connecting the world's leading polymer producers with thousands of OEMs and brand owners across healthcare, consumer, industrial, and mobility markets. Powered by technical and commercial expertise, it brings a distinctive combination of portfolio depth, supply chain strength, industry knowledge, service, leading e-commerce capabilities, and ingenuity. The experienced Formerra team helps customers across multiple industries to design, select, process, and develop products in new and better ways - driving improved performance, productivity, reliability, and sustainability. To learn more, visit www.formerra.com.

About GEON Performance Solutions
GEON® Performance Solutions unlocks the power of polymers for the future. From biomedical materials from our medical division, Foster, LLC, to building materials, automotive, connectivity, and appliances, customers in these markets rely on the portfolio of compounding solutions, highly adaptable vinyl, polyolefin, engineered resin technologies, and full-service contract manufacturing that we deliver. In every formulation, collaboration, and challenge we're shaping the brilliance of tomorrow and providing a formidable advantage by engineering what's possible. Geon has approximately 1,200 global associates and 15 world-class manufacturing plants with headquarters in Westlake, Ohio. Learn more at www.geon.com. Geon is a portfolio company of SK Capital Partners.

Media Contact
Jackie Morris
Marketing Communications Manager, Formerra
[email protected]
+1 630-972-3144

SOURCE: Formerra



View the original press release on ACCESS Newswire

T.Shimizu--JT